Epilepsy Action supports the All Trials campaign. It is important that our members know that we support the full publication of all clinical and research data. Transparency in all clinical trials is needed to allow prescribers to make recommendations in full knowledge of the facts. It will also allow patients to make informed choices about the potential benefits and possible side-effects of their treatments. The availability of more information will also enable independent experts to assess the effectiveness and safety of new drugs. Without this knowledge, we cannot be sure that patients are receiving the best care.
